Cargando…
An Anti-Parkinson’s Disease Drug via Targeting Adenosine A(2A) Receptor Enhances Amyloid-β Generation and γ-Secretase Activity
γ-secretase mediates the intramembranous proteolysis of amyloid precursor protein (APP) and determines the generation of Aβ which is associated with Alzheimer’s disease (AD). Here we identified that an anti-Parkinson’s disease drug, Istradefylline, could enhance Aβ generation in various cell lines a...
Autores principales: | Lu, Jing, Cui, Jin, Li, Xiaohang, Wang, Xin, Zhou, Yue, Yang, Wenjuan, Chen, Ming, Zhao, Jian, Pei, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106031/ https://www.ncbi.nlm.nih.gov/pubmed/27835671 http://dx.doi.org/10.1371/journal.pone.0166415 |
Ejemplares similares
-
Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A(2A) Receptor Enhances Amyloid-β Generation and γ-Secretase Activity
Publicado: (2017) -
Targeting the γ-/β-secretase interaction reduces β-amyloid generation and ameliorates Alzheimer’s disease-related pathogenesis
por: Cui, Jin, et al.
Publicado: (2015) -
β-Arrestin1 regulates γ-secretase complex assembly and modulates amyloid-β pathology
por: Liu, Xiaosong, et al.
Publicado: (2013) -
Making the final cut: pathogenic amyloid-β peptide generation by γ-secretase
por: Steiner, Harald, et al.
Publicado: (2018) -
Substrate interaction inhibits γ-secretase production of amyloid-β peptides
por: Zhao, Jing, et al.
Publicado: (2020)